Nalaganje...
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
BACKGROUND: Endometrial cancer is one of the most common gynaecological cancers in developed countries. Treatment of advanced endometrial cancer usually involves radiotherapy, chemotherapy, endocrine therapy or a combination of these. However, survival outcomes are poor in advanced or metastatic dis...
Shranjeno v:
| izdano v: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2019
|
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953296/ https://ncbi.nlm.nih.gov/pubmed/31588998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012160.pub2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|